drugset / Trial / NCT02830542
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The study will involve administering a single dose of investigational drug or placebo in ascending dose cohorts. This study is designed to evaluate the safety and tolerability of investigational drug as well as the efficacy of investigational drug versus placebo in adults with primary (first episode) Clostridium difficile infection (CDI).
Timeline
- Start
- 2016-08
- Primary completion
- 2018-05
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SER-262 | Other / unclassified | 10000 unknown | Oral |
| Subject | SER-262 | Other / unclassified | 100000 unknown | Oral |
| Subject | SER-262 | Other / unclassified | 1e+06 unknown | Oral |
| Subject | SER-262 | Other / unclassified | 1e+07 unknown | Oral |
| Subject | SER-262 | Other / unclassified | 1e+08 unknown | Oral |